Garlan Adams
General Counsel at CRINETICS PHARMACEUTICALS, INC.
Network origin in Garlan Adams first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
| Subsidiary | Pharmaceuticals: Major | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Garlan Adams via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| ENCORE CAPITAL GROUP, INC. | Finance/Rental/Leasing | Human Resources Officer | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Balyasny Asset Management LP
 Balyasny Asset Management LP Investment ManagersFinance Balyasny Asset Management LP (BAM) is a multi-strategy hedge fund manager and SEC-registered investment advisor headquartered in Chicago, Illinois. The firm’s predecessor, Balyasny Capital Management LLC (BCM), was founded in 2001 by Dmitry Balyasny, Scott Schroeder and Taylor O'Malley. In 2003, BCM converted from a limited liability company to a limited partnership. Then, in January 2004, their name was changed to Balyasny Asset Management LP. They are a subsidiary of Balyasny Asset Management Holdings LP. BAM provides investment advisory services to high net-worth individuals and institutional clients through privately offered pooled investment funds. | Investment Managers | Analyst-Equity | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| Indiana University | College/University | Undergraduate Degree | |
| Nova Southeastern University, Inc. | College/University | Masters Business Admin Masters Business Admin | |
| Pepperdine University | College/University | Masters Business Admin Masters Business Admin | |
| Southwestern Oklahoma State University | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
| University of Kansas | College/University | Doctorate Degree Undergraduate Degree | |
| University of Louisiana at Monroe | College/University | Undergraduate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| Federal University of Rio de Janeiro | College/University | Doctorate Degree | |
| Capella University LLC | College/University | Masters Business Admin | |
Boston Healthcare Associates, Inc.
 Boston Healthcare Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Healthcare Associates, Inc. provides medical consulting services. It offers services in following areas reimbursement and market Access, health economics and outcomes research, pricing and market analytics, business development and licensing. It has experience in treatment of acute and chronic pain, alternative and holistic medicines, asthma and respiratory conditions, autoimmune and blood disorders, renal disease and wound care. The company was founded by Andrew J. Ferrara, Sr. in 1993 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| TALPHERA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu. | Miscellaneous Commercial Services | Director/Board Member | |
Ipsen, Inc.
 Ipsen, Inc. Industrial MachineryProducer Manufacturing Ipsen, Inc. design and manufacture of industrial atmosphere and vacuum heat-treating systems and supervisory controls systems. It offers vacuum furnaces, atmosphere furnaces, and PdMetrics software platform. The company was founded by Harold Ipsen in 1948 and is headquartered in Cherry Valley, IL. | Industrial Machinery | Corporate Officer/Principal | |
| Northeast Louisiana University | College/University | Undergraduate Degree | |
ScienceMedia, Inc.
 ScienceMedia, Inc. Electronics DistributorsDistribution Services ScienceMedia, Inc. provides marketing, communication, and e-learning solutions for life sciences and higher education markets. It offers solutions through the Web site and intranet, as well as through CD-ROMs. The company was founded by Arnold T. Hagler in 1995 and is headquartered in San Diego, CA. | Electronics Distributors | Founder | |
| Accesia, Inc. | President | ||
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Comptroller/Controller/Auditor | |
| BIOVERATIV INC | Biotechnology | Corporate Officer/Principal | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| LONGEVERON INC. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The San Diego Entrepreneurs Exchange | Founder | ||
| ALPHA COGNITION INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| One Joule, LLC | Corporate Officer/Principal | ||
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | Pharmaceuticals: Major | Founder |
Statistics
International
| United States | 47 |
| Brazil | 2 |
| Bermuda | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Finance | 3 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 84 |
| Corporate Officer/Principal | 71 |
| Independent Dir/Board Member | 39 |
| Undergraduate Degree | 30 |
| Chief Tech/Sci/R&D Officer | 27 |
Most connected contacts
| Insiders | |
|---|---|
| Wendell Wierenga | 23 |
| Camille Bedrosian | 18 |
| Keith Katkin | 16 |
| Stephen W. Kaldor | 16 |
| Matthew Fust | 16 |
| Joao Siffert | 14 |
| Caren Deardorf | 11 |
| Gina Ford | 11 |
| Rohan Palekar | 10 |
| Michael McFadden | 9 |
| Rogério Vivaldi Coelho | 9 |
| Adriana Cabré | 9 |
| Dana Pizzuti | 9 |
| Stephanie Okey | 9 |
| Aziz Mottiwala | 8 |
- Stock Market
- Insiders
- Garlan Adams
- Company connections
